Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001933414-26-000039
Filing Date
2026-02-20
Accepted
2026-02-20 19:47:02
Documents
1
Period of Report
2026-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771634819.html 4  
1 FORM 4 wk-form4_1771634819.xml 4 6279
  Complete submission text file 0001933414-26-000039.txt   7747
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
DiRocco Derek (Reporting) CIK: 0001792061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 26661828

Mailing Address 150 N. RADNOR CHESTER RD. SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER RD. SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)